Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome-Reference-Cited by-同舟云学术

Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome

Published:2023-11-05 Issue:12 Volume:72 Page:4261-4278
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Minz Aliva Prity,Mohapatra Debasish,Dutta Madhuri,Sethi Manisha,Parida Deepti,Mohapatra Amlan Priyadarshee,Mishra Swayambara,Kar Salona,Sasmal Prakash K.,Senapati Shantibhusan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-023-03562-9.pdf

Reference74 articles.

1. Siegel RL et al (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7–33

2. Rahib L et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921

3. Sawada M et al (2020) Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer. BMC Cancer 20(1):1–9

4. Citterio C et al (2018) Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis. Oncotarget 9(51):29801

5. Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell 38(6):788–802

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment;Drug Discovery Today;2024-09

2. CAFs and T cells interplay: The emergence of a new arena in cancer combat;Biomedicine & Pharmacotherapy;2024-08

3. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer;International Journal of Surgery;2024-05-13

4. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells;International Journal of Molecular Sciences;2024-03-11

5. Pdgfrβ Participates in the Stat3-Mediated Regulation of Pd-L1 Expression in Colorectal Cancer;2024